GENENTECH ALLEGED PROTROPIN PHYSICIAN INDUCEMENT OF OFF-LABEL USE UNDER FDA INVESTIGATION; AGENCY HAS LIMITED AUTHORITY OVER FOUNDATIONS, KICKBACKS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".